Back

Impact of extracorporeal cardiopulmonary resuscitation with ECPELLA on improvement of short-term survival in patients with refractory cardiac arrest

1 September 2024 (10:45 - 10:55)
Organised by: Logo
Congress Presentation Part of: The best science in cardiac arrest and cardiogenic shock Resuscitation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Taiji Inamori

Saiseikai Kumamoto Hospital, Kumamoto (Japan)

5 More presentations in this session

Presentation thumbnail
Increased miRNA-related inflammation markers and pro-inflammatory circulating cell profile in patients with poor neurological outcome after out-of-hospital cardiac arrest
Mr F. Jimenez Trinidad (Barcelona, ES) Doctor R. Andrea Riba (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Sex-specific prediction of cardiogenic shock complicating acute coronary syndromes: the SEX-SHOCK score
Ms Y. Wang (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
The majority of 30-days survivors return to work one-year after in-hospital cardiac arrest
Doctor H. Yonis (Hilleroed, DK)
Abstract Slides Video
Presentation thumbnail
The effects of targeting mild hypercapnia on right ventricular function after out-of-hospital cardiac arrest. A sub-study of the TAME trial.
Doctor M. Baumann Melberg (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Clinical significance of residual ischemia in acute myocardial infarction complicated by cardiogenic shock undergoing VA-ECMO
Doctor O. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
The best science in cardiac arrest and cardiogenic shock
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 10:45 CET
You may be interested in
thumbnail
Congress Presentation
The short-term prognosis and associated factors in E-CPR patients with ECPELLA: UNLOADERS-PVAD registry
thumbnail
Congress Session
The best science in cardiac arrest and cardiogenic shock
thumbnail
Congress Presentation
ECPR for OHCA is a rationale indication

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources